Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meis homeobox 3 (MEIS3) encodes a nuclear homeobox protein that acts as a sequence-specific transcriptional regulator, controlling the expression of genes critical for embryonic development, tissue differentiation, and cellular proliferation. MEIS3 is highly conserved and has functional orthologs across species; in mouse models, it modulates the expression of PDPK1, influencing pancreatic beta-cell survival. During development, MEIS3 is crucial for the proper migration and proliferation of neural crest cells destined for the enteric nervous system, and its loss leads to profound developmental defects, including colonic aganglionosis. MEIS3 also interacts with PBX1 and other transcription factors as part of protein complexes that precisely regulate gene expression. While not a canonical drug target, aberrations in MEIS3-regulated transcription could influence disease processes, especially developmental disorders and potentially cancer biology, although direct targeting by therapeutics is not established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meis homeobox 3 (MEIS3).